Rivals Say Boniva Made False Claims

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Procter & Gamble Pharmaceuticals and Sanofi-Aventis have sued Roche Pharmaceuticals and GlaxoSmithKline, alleging that advertising for the osteoporosis drug Boniva is false and misleading, according to P&G.

Boniva, marketed jointly by Roche and GSK, is a once-a-month osteoporosis pill launched last April. P&G and Sanofi jointly market a rival treatment, Actonel.

The plaintiffs specifically allege that the Boniva advertising wrongly claims that Boniva reduces the risk of non-spine fractures at rates comparable to other treatments.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in